Could the FDA’s Approval of a New Drug to Treat Alzheimer’s Disease do More Harm than Good?
A conversation with Dr. Jason Karlawish, MD.
A conversation with Dr. Jason Karlawish, MD.
Subscribe now to stay informed with the latest news and insights from CAPRA!